Núria Martínez‐Cibrián

1.1k total citations
23 papers, 286 citations indexed

About

Núria Martínez‐Cibrián is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Núria Martínez‐Cibrián has authored 23 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 4 papers in Genetics and 4 papers in Immunology. Recurrent topics in Núria Martínez‐Cibrián's work include CAR-T cell therapy research (16 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Núria Martínez‐Cibrián is often cited by papers focused on CAR-T cell therapy research (16 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Núria Martínez‐Cibrián collaborates with scholars based in Spain, Belgium and Slovakia. Núria Martínez‐Cibrián's co-authors include Josè Antonio Pérez-Simón, Robert Zeiser, Valentín Ortiz‐Maldonado, Julio Delgado, Mariona Pascal, Álvaro Urbano-Ispizúa, Marta Español‐Rego, Juan Luis Reguera, A Caballero and Alejandro Martı́n and has published in prestigious journals such as Blood, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Núria Martínez‐Cibrián

21 papers receiving 283 citations

Peers

Countries citing papers authored by Núria Martínez‐Cibrián

Since Specialization

Citations

This map shows the geographic impact of Núria Martínez‐Cibrián's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Núria Martínez‐Cibrián with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Núria Martínez‐Cibrián more than expected).

Fields of papers citing papers by Núria Martínez‐Cibrián

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Núria Martínez‐Cibrián. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Núria Martínez‐Cibrián. The network helps show where Núria Martínez‐Cibrián may publish in the future.

Co-authorship network of co-authors of Núria Martínez‐Cibrián

This figure shows the co-authorship network connecting the top 25 collaborators of Núria Martínez‐Cibrián. A scholar is included among the top collaborators of Núria Martínez‐Cibrián based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Núria Martínez‐Cibrián. Núria Martínez‐Cibrián is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Endothelial dysfunction and hemostatic imbalance in CAR T-cell-associated toxicities: pathophysiological insights and the role of circulating biomarkers 2025 ·Frontiers in Immunology ·Ana Belén Moreno‐Castaño, (unknown), Núria Martínez‐Cibrián, (unknown), Dolores Prats, Julia Martínez-Sánchez, Pedro Castro, Maribel Díaz‐Ricart	0
2	Euplagia-1: A Phase 1/2 Trial of GLPG5201, a Fresh Stem-like Early Memory CD19 CAR T-Cell Therapy with a 7-Day Vein-to-Vein Time, in Patients with Relapsed/Refractory CLL and RT 2024 ·Blood ·(unknown), Núria Martínez‐Cibrián, (unknown), (unknown), (unknown), Sandra Blum, (unknown), Marte C. Liefaard, Margot J. Pont, (unknown), Kirsten Van Hoorde, (unknown), Julio Delgado, Natalia Tovar	1
3	The role of chimeric antigen receptor T cells targeting more than one antigen in the treatment of B‐cell malignancies 2024 ·British Journal of Haematology ·(unknown), Núria Martínez‐Cibrián, (unknown), (unknown), Valentín Ortiz‐Maldonado, Sònia Guedan, Julio Delgado	8
4	CD19-Directed CAR T-Cells in a Patient With Refractory MOGAD 2024 ·Neurology Neuroimmunology & Neuroinflammation ·(unknown), María Sepúlveda, Raquel Ruiz‐García, (unknown), Núria Martínez‐Cibrián, Valentín Ortiz‐Maldonado, (unknown), Mar Guasp, Sara Llufriú, Eugenia Martínez‐Hernández, Thaís Armangué, (unknown), (unknown), (unknown), Josep Dalmau, Manel Juan, Albert Saiz, Yolanda Blanco	16
5	Rheumatologic complications of CAR-T Cell therapy. Experience of a single center 2024 ·Seminars in Arthritis and Rheumatism ·José A. Gómez‐Puerta, Ana Monegal, Andrés Ponce, Pilar Peris, Núria Martínez‐Cibrián, Juan Camilo Sarmiento-Monroy, Valentín Ortiz‐Maldonado, (unknown), Carlos Fernández de Larrea, Julio Delgado, Adriana García‐Herrera, (unknown), Xavier Bosch‐Amate, Marta Español‐Rego, Europa Azucena González‐Navarro, Raimón Sanmartí, Manel Juan	1
6	Increased Serum Levels of N-terminal pro-B-type Natriuretic Peptide (NT-proBNP) in Mobilized Healthy Donors with G-CSF: A Cohort Study 2024 ·Transfusion Medicine Reviews ·Joan Cid, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), José Alcaraz‐Quiles, (unknown), Núria Martínez‐Cibrián, María Queralt Salas, María Suárez‐Lledó, Laura Rosiñol, Francesc Fernández‐Avilés, Carmen Martı́nez, Montserrat Rovira, Miquel Lozano	1
7	Treatment with Siltuximab for Short Term Complications after Chimeric Antigen Receptor T-Cell Therapy: A Multicenter Retrospective Analysis 2024 ·Blood ·José María Sánchez‐Pina, (unknown), Lucía López‐Corral, Anabelle Chinea, (unknown), Núria Martínez‐Cibrián, Rafael Hernani, Víctor Noriega, (unknown), Pascual Balsalobre, María Calbacho, (unknown), Pere Barba, Mi Kwon	0
8	Infection epidemiology in relation to different therapy phases in patients with haematological malignancies receiving CAR T‐cell therapy 2023 ·European Journal Of Haematology ·(unknown), Valentín Ortiz‐Maldonado, Olivier Peyrony, Mariana Chumbita, Tommaso Francesco Aiello, Patricia Monzó, (unknown), Pedro Puerta‐Alcalde, Laura Magnano, Núria Martínez‐Cibrián, Cristina Pitart, Manel Juan, Julio Delgado, Carlos Fernández de Larrea, Àlex Soriano, Álvaro Urbano-Ispizúa, Carolina García‐Vidal	2
9	Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals 2023 ·Journal of Antimicrobial Chemotherapy ·Tommaso Francesco Aiello, Pedro Puerta‐Alcalde, Mariana Chumbita, (unknown), Patricia Monzó, (unknown), Francesc Fernández‐Avilés, María Suárez‐Lledó, Juan Gonzalo Correa, Valentín Ortiz‐Maldonado, Genoveva Cuesta, Núria Martínez‐Cibrián, Jordi Esteve, María Ángeles Marcos, Josep Mensa, Àlex Soriano, Carolina García‐Vidal	8
10	Practical aspects of chimeric antigen receptor T-cell administration: From commercial to point-of-care manufacturing 2022 ·Frontiers in Immunology ·Núria Martínez‐Cibrián, Marta Español‐Rego, Mariona Pascal, Julio Delgado, Valentín Ortiz‐Maldonado	20
11	Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter’s Transformation 2022 ·Frontiers in Oncology ·Valentín Ortiz‐Maldonado, Gerard Frigola, Marta Español‐Rego, Olga Balagué, Núria Martínez‐Cibrián, Laura Magnano, Eva Giné, Mariona Pascal, Juan Gonzalo Correa, (unknown), Joan Cid, Miquel Lozano, Neus Villamor, Daniel Benítez‐Ribas, Jordi Esteve, Armando López‐Guillermo, Elı́as Campo, Álvaro Urbano-Ispizúa, Manel Juan, Julio Delgado	21
12	PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCT 2022 ·Transplantation and Cellular Therapy ·María Queralt Salas, (unknown), Alexandra Pedraza, Núria Martínez‐Cibrián, (unknown), Ariadna Domènech, María Suárez‐Lledó, Meritxell Nomdedéu, Joan Cid, Miquel Lozano, (unknown), (unknown), Laura Rosiñol, Gonzalo Gutiérrez, Enric Carreras, Jordi Esteve, Álvaro Urbano-Ispizúa, Francesc Fernández‐Avilés, Montserrat Rovira, Carmen Martı́nez	8
13	Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib 2022 ·Scientific Reports ·Alfonso Rodríguez‐Gil, (unknown), (unknown), (unknown), (unknown), (unknown), Estefanía García‐Guerrero, Cristina Calderón‐Cabrera, Teresa Caballero‐Velázquez, (unknown), (unknown), Juan Luis Reguera, (unknown), Núria Martínez‐Cibrián, José-Ignacio Rodríguez-Barbosa, Javier Villadiego, Josè Antonio Pérez-Simón	9
14	T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells 2022 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Aina Oliver‐Caldés, María Suárez‐Lledó, Miquel Lozano, (unknown), Núria Martínez‐Cibrián, Joan Cid, David F. Moreno, Luis Gerardo Rodríguez‐Lobato, Álvaro Urbano-Ispizúa, Carlos Fernández de Larrea	8
15	Cytopenias in CAR-T Cell Therapy and Use of Transfusion Resources in Adult Patients with Lymphoproliferative Disorders 2021 ·Blood ·(unknown), María Eva Mingot‐Castellano, (unknown), (unknown), (unknown), Juan Luís Reguera, Núria Martínez‐Cibrián, (unknown), (unknown), (unknown), (unknown), Josè Antonio Pérez-Simón	3
16	Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma 2021 ·Cancer Medicine ·Gloria Iacoboni, Guillermo Villacampa, Núria Martínez‐Cibrián, Rebeca Bailén, Lucía López‐Corral, (unknown), Manuel Guerreiro, A Caballero, Alberto Mussetti, Juan‐Manuel Sancho, Rafael Hernani, Pau Abrisqueta, Carlos Solano, Anna Sureda, Javier Briones, Alejandro Martı́n, Mi Kwon, Juan Luis Reguera, Pere Barba, (unknown)	81
17	Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions 2020 ·Blood Reviews ·Núria Martínez‐Cibrián, Robert Zeiser, Josè Antonio Pérez-Simón	55
18	Real-World Evidence of Tisagenlecleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma 2020 ·Blood ·Gloria Iacoboni, (unknown), Núria Martínez‐Cibrián, Rebeca Bailén, Lucía López‐Corral, (unknown), Manuel Guerreiro, (unknown), Alberto Mussetti, Juan‐Manuel Sancho, Rafael Hernani, Carlos Solano, Anna Sureda, Javier Briones, Alejandro Martı́n, Mi Kwon, Juan Luís Reguera, Pere Barba	4
19	Quantitative PCR Is Faster, More Objective, and More Reliable Than Immunohistochemistry for the Diagnosis of Cytomegalovirus Gastrointestinal Disease in Allogeneic Stem Cell Transplantation 2019 ·Biology of Blood and Marrow Transplantation ·María Suárez‐Lledó, María Ángeles Marcos, Míriam Cuatrecasas, Josep Antoni Bombí, Francesc Fernández‐Avilés, Laura Magnano, Núria Martínez‐Cibrián, (unknown), Laura Rosiñol, Gonzalo Gutiérrez, Sofía Jorge, Carmen Martı́nez, Montserrat Rovira, Álvaro Urbano-Ispizúa	17
20	Deleterious Effect of Steroids on Cytomegalovirus Infection Rate after Allogeneic Stem Cell Transplantation Depends on Pretransplant Cytomegalovirus Serostatus of Donors and Recipients 2018 ·Biology of Blood and Marrow Transplantation ·María Suárez‐Lledó, Núria Martínez‐Cibrián, Gonzalo Gutiérrez, (unknown), Ma Ángeles Marcos, Beatriz Martín-Antonio, Alejandra Martínez‐Trillos, Neus Villamor, Laura Rosiñol, Carmen Martı́nez, Francesc Fernández‐Avilés, Carolina García‐Vidal, Álvaro Urbano-Ispizúa, Montserrat Rovira	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact